Brought to you by 
Qualcomm leads $10mm Series A round for Edico Genome
17 Jul 2014
Executive Summary
Qualcomm Ventures led a $10mm Series A round for Edico Genome Inc. (genomic data processing). Axon Ventures also participated along with Greg Lucier, the former chairman and CEO of Life Technologies (which Thermo Fisher Scientific acquired for $15.2bn in 2013). Lucier also joined Edico’s board.
Deal Industry
- Research, Analytical Equipment & Supplies
- Services
-
Biotechnology
- Synthesis Technologies, Production Processes
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Qualcomm leads $10mm Series A round for Edico Genome
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice